Welcome to the HHS Guidelines for the use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents with Australian commentary
Changes in arrangements for the Provision of Clinical Advice on HIV Management:
Following a review of reporting arrangements and effective from 1 December 2012, the Australasian Society for HIV Medicine has taken on responsibility for the development of a commentary to the DHHS Antiretroviral Guidelines. Since 2005 this work has been done by an independent Antiretroviral Guidelines Panel. The ASHM Board would like to thank the Panel for devoting a huge amount of time to reviewing evidence and providing a detailed commentary to assist clinicians in their management of HIV.
In January 2013 ASHM sent out calls for nominations for a Sub-Committee for Guidance on HIV Management in Australia. The members have now been selected and we are in the process of updating this website. Please check back soon for the list of members and their disclosure of interests. New DHHS Antiretroviral Guidelines were released on February 12, 2013 and can be found here.
The 2012 Guidelines and commentary will continue to be available from this site. ASHM is going through a significant website redevelopment exercise and is reviewing the way it will present clinical advice on HIV management. The way the guidelines and any commentary is presented will be reviewed in that context and the new HIV Guidelines Sub-Committee will contribute to that process.
For any questions or feedback please contact arvg@ashm.org.au
This Australian Commentary to the USA Guidelines for the use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents has been prepared by the Australian Antiretroviral Guidelines Panel. Secretariat and technical support is provided by the Australasian Society for HIV Medicine. Every care has been taken in its compilation.
The Australian Commentary to the USA Guidelines is intended to be used as a guide only and not as an authoritative statement of every conceivable step or circumstance which could be expected to manifest itself in clinical management.
In Australia, authorisation to prescribe antiretroviral drugs is restricted to appropriately trained and certified practitioners. The Australian Commentary to the USA Guidelines is not a self-help guide and should only be used in the Australian context.
Appropriately trained and certified medical practitioners should use this information as a guide to the use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents on the basis of clinical findings, and not as a complete or authoritative statement of such use.
ASHM shall not be liable to users of the Australian Commentary to the US DHHS Guidelines nor to any other person, firm, company or other body for any loss, direct, indirect or consequential, in contract or in tort or for any negligent mis-statement or omission contained herein, by reason of, arising from or in relation to any such user, other person, company or body relying or acting upon or purporting to rely or act upon any information contained in the Australian Commentary to the US DHHS Guidelines.
Tell us what you think. Your feedback is valued and will assist us in keeping this resource current. Please contact us for previous versions of the Australian Commentary.
The ARV Guidelines with Australian commentary is administered by ASHM
Funding is provided by the Australian Government, Department of Health and Ageing
